Lobe Sciences Statistics

Total Valuation

Lobe Sciences has a market cap or net worth of CAD 11.10 million. The enterprise value is 13.75 million.

Market Cap	11.10M
Enterprise Value	13.75M

Important Dates

The last earnings date was Thursday, July 24, 2025.

Earnings Date	Jul 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Lobe Sciences has 201.73 million shares outstanding. The number of shares has decreased by -10.98% in one year.

Current Share Class	201.73M
Shares Outstanding	201.73M
Shares Change (YoY)	-10.98%
Shares Change (QoQ)	+3.43%
Owned by Insiders (%)	21.73%
Owned by Institutions (%)	n/a
Float	129.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	3.28
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.59
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.73.

Current Ratio	2.87
Quick Ratio	2.86
Debt / Equity	0.73
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.88

Financial Efficiency

Return on equity (ROE) is -480.97% and return on invested capital (ROIC) is -53.29%.

Return on Equity (ROE)	-480.97%
Return on Assets (ROA)	-37.20%
Return on Invested Capital (ROIC)	-53.29%
Return on Capital Employed (ROCE)	-56.87%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Lobe Sciences has paid 33,000 in taxes.

Income Tax	33,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +175.00% in the last 52 weeks. The beta is 1.84, so Lobe Sciences's price volatility has been higher than the market average.

Beta (5Y)	1.84
52-Week Price Change	+175.00%
50-Day Moving Average	0.04
200-Day Moving Average	0.03
Relative Strength Index (RSI)	60.24
Average Volume (20 Days)	169,342

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-249,306
Operating Income	-2.97M
Pretax Income	-5.44M
Net Income	-5.32M
EBITDA	-2.90M
EBIT	-2.97M
Earnings Per Share (EPS)	-0.04

Full Income Statement

Balance Sheet

The company has 7.97 million in cash and 2.47 million in debt, giving a net cash position of 5.50 million or 0.03 per share.

Cash & Cash Equivalents	7.97M
Total Debt	2.47M
Net Cash	5.50M
Net Cash Per Share	0.03
Equity (Book Value)	3.39M
Book Value Per Share	-0.02
Working Capital	5.22M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.03M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Lobe Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	10.98%
Shareholder Yield	10.98%
Earnings Yield	-47.93%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 10, 2022. It was a reverse split with a ratio of 0.166666667.

Last Split Date	Jun 10, 2022
Split Type	Reverse
Split Ratio	0.166666667

Scores

Lobe Sciences has an Altman Z-Score of -7.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.34
Piotroski F-Score	3